Search results for “EGFR inhibitors” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 1,932 patents, we discovered top 210 key players by total patent application. F. Hoffmann-La Roche Ltd., Novartis AG, Genentech, Inc. are dominant in this area. They take 24.74% of the total patent filing.
Switzerland
Patent: 275
Basel-Stadt, Switzerland
Patent: 112
California, United States
Patent: 91
Jiangsu Sheng, China
Patent: 67
Rheinland-Pfalz, Germany
Patent: 49
Shanghai Shi, China
Patent: 49
Zhejiang Sheng, China
Patent: 48
Massachusetts, United States
Patent: 41
Massachusetts, United States
Patent: 40
California, United States
Patent: 38
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 70 patents, we discovered top 12 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Felicitex Therapeutics, Inc., Lutris Pharma Ltd. are active in this area.
STARTUP
France
Patent: 22
STARTUP
Massachusetts, United States
Patent: 16
STARTUP
Israel
Patent: 10
STARTUP
ZURICH, Switzerland
Patent: 5
STARTUP
South Korea
Patent: 4
STARTUP
Shanghai Shi, China
Patent: 4
STARTUP
British Columbia, Canada
Patent: 3
STARTUP
Pennsylvania, United States
Patent: 2
STARTUP
Sichuan Sheng, China
Patent: 1
STARTUP
South Korea
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 771 patents applied in the last 5 years. We discover 165 most active companies in this area. The fast-growing F. Hoffmann-La Roche Ltd., Dana-Farber Cancer Institute, Inc., Betta Pharmaceuticals Co., Ltd. take 24.90% of patent filing during this period.
Switzerland
Patent: 88
Massachusetts, United States
Patent: 68
Zhejiang Sheng, China
Patent: 36
Jiangsu Sheng, China
Patent: 35
Massachusetts, United States
Patent: 23
Shanghai Shi, China
Patent: 22
Tokyo-to, Japan
Patent: 21
Shanghai Shi, China
Patent: 18
Maharashtra, India
Patent: 18
Shandong Sheng, China
Patent: 18
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 771 patents in last 5 years, we discover 111 new entrants. Blueprint Medicines Corp., Abbisko Therapeutics Co., Ltd., Lupin Ltd are the most active new entrants in this area.
Massachusetts, United States
Patent: 23
Shanghai Shi, China
Patent: 22
Maharashtra, India
Patent: 18
Shandong Sheng, China
Patent: 18
Israel
Patent: 16
Shanghai Shi, China
Patent: 15
California, United States
Patent: 12
South Korea
Patent: 10
Massachusetts, United States
Patent: 10
California, United States
Patent: 10
Research Institutions
Order by:
Innovation Intensity
With the analysis among 282 patents, we discovered top 60 universities and scientific research institutions by total patent application. Regents of the University of Colorado, East China University of Science & Technology, The Johns Hopkins University are dominant in this area. They take 23.40% of the total patent filing.
Colorado, United States
Patent: 22
Shanghai Shi, China
Patent: 16
United States
Patent: 7
Delhi, India
Patent: 7
Kyoto-fu, Japan
Patent: 6
Institut Gustave Roussy EURL
France
Patent: 6
France
Patent: 6
CENTRE COUNTY, France
Patent: 5
Niigata-ken, Japan
Patent: 4
Victoria, Australia
Patent: 3
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: